Understand the complete disease landscape and size global markets with real-world data. DRG’s Epidemiology cover 140+ diseases, 40+ countries, 3,400 patient segments, including extensive insights of oncology populations by stage, line of therapy, and biomarker. Learn more about DRG Epidemiology here.

The poster below was presented by DRG Epidemiologists Deepti Sharma, BDS, MPH, Atul Sharma, BDS,MPH; Jayati Saha, PhD; Alison Isherwood, MSc, PhD, at Biomarkers India on Global Forecast of FLT3 Mutations Among Acute Myeloid Leukemia Patients Over The Next Ten Years.

 

 

 

 

How Glympse Bio oversubscribed their Series B funding amidst the pandemic

View Now